Funding for this research was provided by:
Medical Research and Materiel Command
Received: 17 September 2019
Accepted: 1 October 2019
First Online: 19 October 2019
Ethics approval and consent to participate
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. Research was conducted in an AAALACi accredited facility in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 2011 edition.
: All authors provide their consent for publication of the manuscript.
: Authors declare no competing interests except for Dr. Evelina Angov who declares a competing interest; she holds an issued US patent on the recombinant PfCelTOS and its use.